Fimasartan (Kanarb)


Indications


Pharmacology

Fimasartan is an Angiotensin II Receptor Blocker (ARB) (see Angiotensin II Receptor Blockers)

  • xxx

Metabolism

  • xxx

Administration

Oral (PO)

Dose Adjustment

Concomitant Administration of ACE Inhibitors and ARB’s (see Angiotensin Converting Enzyme Inhibitors and see Angiotensin II Receptor Blockers)


Adverse Effects

Allergic/Immunologic Adverse Effects

Angioedema (see Angioedema)

Cardiovascular Adverse Effects

Hypotension (see Hypotension)

Syncope (see Syncope)

Endocrinologic Adverse Effects

Drug-Induced Hypoaldosteronism (see Hypoaldosteronism)

Pulmonary Adverse Effects

Cough (see Cough)

Renal Adverse Effects

Acute Kidney Injury (AKI) (see Acute Kidney Injury)

Hyperkalemia (see Hyperkalemia)

Non-Anion Gap Metabolic Acidosis (see Metabolic Acidosis-Normal Anion Gap)


References